ES333664A1 - Un procedimiento para la preparacion de agentes antibacterianos. - Google Patents

Un procedimiento para la preparacion de agentes antibacterianos.

Info

Publication number
ES333664A1
ES333664A1 ES0333664A ES333664A ES333664A1 ES 333664 A1 ES333664 A1 ES 333664A1 ES 0333664 A ES0333664 A ES 0333664A ES 333664 A ES333664 A ES 333664A ES 333664 A1 ES333664 A1 ES 333664A1
Authority
ES
Spain
Prior art keywords
translation
preparation
machine
legally binding
google translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0333664A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES333664A1 publication Critical patent/ES333664A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/58Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with a nitrogen atom, which is a member of a hetero ring, attached in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES0333664A 1965-11-24 1966-11-22 Un procedimiento para la preparacion de agentes antibacterianos. Expired ES333664A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US509627A US3303193A (en) 1965-11-24 1965-11-24 Derivatives of cephalosporanic acid

Publications (1)

Publication Number Publication Date
ES333664A1 true ES333664A1 (es) 1967-12-01

Family

ID=24027438

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0333664A Expired ES333664A1 (es) 1965-11-24 1966-11-22 Un procedimiento para la preparacion de agentes antibacterianos.

Country Status (13)

Country Link
US (1) US3303193A (es)
BE (1) BE689995A (es)
BR (1) BR6684800D0 (es)
CH (1) CH477476A (es)
CY (1) CY667A (es)
DE (1) DE1670163C3 (es)
DK (1) DK112944B (es)
ES (1) ES333664A1 (es)
FR (2) FR1516019A (es)
GB (1) GB1162247A (es)
MY (1) MY7300189A (es)
NL (2) NL6616444A (es)
SE (1) SE348203B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061862A (en) * 1975-10-06 1977-12-06 Bristol-Myers Company Derivatives of 7-(cyclized)phenylglycyl-3-triazolo-thio methyl cephalosporin
US4064345A (en) * 1975-12-12 1977-12-20 Bristol-Myers Company Cephalosporins derivatives 7-cyclized α-amino-3-heterothio
US4002748A (en) * 1976-01-19 1977-01-11 Eli Lilly And Company Method of preparing sterile essentially amorphous cefazolin for reconstitution for parenteral administration
JPS54112892A (en) * 1978-02-23 1979-09-04 Shionogi & Co Ltd Substituted imidazolidinyl-3-chloro-3-cephem-4-carboxylic acid
US4288590A (en) * 1980-02-14 1981-09-08 Bristol-Myers Company 7-[Dα-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-arylacetamido]-3-(N,N-dimethyl-aminomethylpyridinium) methyl-3-cephem-4-carboxylates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985648A (en) * 1958-10-06 1961-05-23 Doyle Frank Peter Alpha-aminobenzylpenicillins
GB985747A (en) * 1961-09-11 1965-03-10 Lilly Co Eli Cephalosporin compounds
US3198804A (en) * 1963-01-25 1965-08-03 Bristol Myers Co alpha-aminomethylpenicillin derivatives

Also Published As

Publication number Publication date
NL125838C (es)
GB1162247A (en) 1969-08-20
FR6118M (es) 1968-06-17
US3303193A (en) 1967-02-07
BE689995A (es) 1967-05-22
DE1670163A1 (de) 1970-08-13
MY7300189A (en) 1973-12-31
SE348203B (es) 1972-08-28
DK112944B (da) 1969-02-03
DE1670163B2 (de) 1973-04-26
BR6684800D0 (pt) 1973-12-18
CH477476A (de) 1969-08-31
FR1516019A (fr) 1968-03-08
NL6616444A (es) 1967-05-25
CY667A (en) 1972-12-13
DE1670163C3 (de) 1973-11-29

Similar Documents

Publication Publication Date Title
ES306817A1 (es) Procedimiento para preparar un nuevo derivado de isoxazol.
ES413266A1 (es) Un procedimiento para la preparacion de un derivado de aci-do indenilacetico.
ES375933A1 (es) Un metodo de preparar un compuesto de 2-amino-4-hidroxi-6- hidroximetil-7, 7 - dimetil - 7,8 - dihidropteridinao una forma tautomera de la misma.
ES333664A1 (es) Un procedimiento para la preparacion de agentes antibacterianos.
ES303322A1 (es) Procedimiento para la preparacion de derivados de piperidina.
ES432340A1 (es) Procedimiento para preparar el antibiotico 20.798 r. p.
ES284773A1 (es) Un procedimiento para preparar derivados inorgánicos de policondensados básicos de nitrógeno
ES248193A1 (es) Procedimiento para obtener sales basicas cristalinas de productos de reduccion de estreptomicina
ES386714A1 (es) Procedimiento para la preparacion de nuevos derivados de tiepina.
ES298390A3 (es) Un procedimiento para preparar nortriptileno
ES294298A1 (es) Procedimiento para la elaboración de una sal nueva del ácido nicotínico
ES415453A1 (es) Procedimiento de preparacion de n(dietillaminoetil) - 2 - metoxi - 5 - metilsulfonil-benzamida.
ES302637A3 (es) Procedimiento para la preparaciën de agentes para el tratamiento de las escleroproteinas sulfurosas
ES415452A1 (es) Procedimiento de preparacion de n--etil - 2 - pirrolililme-til - 2 - metoxi - 5 -etisulfonil-benzamida.
ES341113A1 (es) Procedimiento para la preparacion de agentes antibacteria- nos.
FR1355946A (fr) Procédé pour la préparation de nouveaux dérivés basiques de la phénoxazine, ainsi que de leurs sels
ES279025A1 (es) Procedimiento de preparaciën de alfa-aminobencilpenicilina
ES286465A1 (es) Procedimiento para la fabricacion de sales insipidas de la n-(5-nitrofurfuriliden)-1-aminohidantoina
ES333231A1 (es) Un procedimiento para la preparacion de 1,2-difenil-3,5-dioxo-4-(3'-oxobutil) pirazolidina.
ES405105A1 (es) Un procedimiento para la preparacion de 2,6,6-trimetil-1-(10' - carboxi - 3',7'-dimetil - deca - 1',3',5',7',9' - pen- taenil)-cicolhexi-eno o una sal del mismo.
ES360632A1 (es) Procedimiento para la obtencion de derivados de rifamicina.
ES302306A1 (es) Procedimiento para la obtención de derivados tetraciclinopenicilínicos en que interviene como elemento de enlace un producto piperacínico
ES308480A1 (es) Procedimiento para la preparacion de nuevas sales del acido embonico.
ES374393A1 (es) Procedimiento para la preparacion de una sal sodica crista-lina de la fenilbutazona.
ES405154A3 (es) Procedimiento para la obtencion de acido 3, 4, 5 trimetoxi-benzoilamidocarboxilico y sus sales.